Reflections on Terms, Goals and Organisation
In this chapter, we address three challenges relating to patient involvement in HTA. Firstly, we reflect on some of the terms often used by HTA researchers, patient organisations and HTA bodies to describe the patients who participate in HTAs including terms such as ‘patient’, ‘patient advocate’, ‘patient representative’, ‘patient partner’ and ‘consumer’. This challenge has previously been described in relation to healthcare in general. Dent and Pahor write: ‘The whole arena of patient involvement within healthcare is riven with problems of meaning, definition and purpose’ (Dent and Pahor 2015). In addition, they argue that the topic is further complicated when one attempts to compare practices across countries (Dent and Pahor 2015). Secondly, we discuss how the choice of term and hence the choice of participants may influence the realisation of goals with patient involvement in HTA. We argue that a challenge lies in confusion about the goals for implementing patient involvement in HTA, particularly when these goals compete with a variety of other goals such as cost containment or decision-making based on strictly defined clinical effectiveness. Thirdly, we address the challenge relating to leadership and organisational change, because some of the goals for patient involvement in HTA will require new ways of organizing and leading HTAs. We briefly introduce three models for organising patient involvement in HTA. The aim of the chapter is to contribute to the current debate on the use of terms to describe patient involvement and the nature of the associated goals and organisation supporting this involvement.
KeywordsCochlear Implant Patient Advocate Patient Involvement Patient Organisation Patient Representative
- Batterbury SCE. Evaluation and exclusion from twhe public arena: the case of the British deaf community: chapter 11. In: Boyle R, Breul JD, Dahler-Larsen, editors. Open to the public: evaluation in the public sector. New Brunswick: Transaction Publishers; 2008.Google Scholar
- Dent M, Pahor M. Patient involvement in Europe – a comparative framework. JHOM. 2015;29:546–55.Google Scholar
- EMA. Revised framework for interaction between the European medicines agency and patients and consumers and their organisations. EMA/637573/2014 adopted. 2014. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2009/12/WC500018013.pdf. Accessed 19 Nov 2016.Google Scholar
- EUPATI, Patient education!. 2016.https://www.eupati.eu/. Accessed 11 Oct 2016.
- Facey K, Boivin A, Gracia J, et al. Patients’ perspectives in health technology assessment: a route to robust evidence and fair liberation. Int J Technol Assess Health Care. 2010;70:1518–26.Google Scholar
- Facey K, et al. Organisation of services for diabetic retinopathy screening. Health technology assessment report 1. Glasgow: Health Technology Board for Scotland; 2001.Google Scholar
- Gauvin FP, Abelson J, Lavis JN. Evidence brief: strengthening public and patient engagement in health technology assessment in Ontario. Hamilton, Canada: McMaster Health Forum; 2015.Google Scholar
- Hansen HP. Evidence-based nursing: must or mantra? In: Kristiansen IS, Mooney G, editors. Evidence-based medicine. In its place. London: Routledge; 2004. p. 33–50.Google Scholar
- Harper, D. Online etymology dictionary, 2001–2016. 2016. http://www.etymonline.com/index.php?term=patient&allowed_in_frame=0. Accessed 11 Oct 2016.
- Hartzler A, Pratt W. Managing the personal side of health: how patient expertise differs from the expertise of clinicians. J Med Internet Res. 2011;13(3) doi: 10.2196/jmir.1728.
- Holm-Petersen C, Navne LE. Hvad er ledelse af brugerinddragelse? En gennemgang af mål og tre individuelle brugerinddragelsesmodeller. (how to lead patient involvement? Goals and models that organize relations). Bruggerinddragelse Tidsskrift for Forskning i Sygdom og Samfund (J Res Sick Soc). 2015;22:103–33.Google Scholar
- HTAi. Interest groups – patient and citizen involvement. 2016a. http://www.htai.org/interest-groups/patient-and-citizen-involvement.html. Accessed 19 Nov 2016 .
- HTAi FAQ for HTA agencies and policy makers. 2016b. http://www.htai.org/interest-groups/patient-and-citizen-involvement/resources/for-hta-agencies-and-policy-makers/faq-for-hta-agencies-and-policy-makers.html. Accessed 29 Nov 2016.
- Jensen UF. Evidence, effectiveness and ethics: cochrane’s legacy. In: Kristiansen IS, Mooney G, editors. Evidence-based medicine. In its place. London: Routledge; 2004. p. 20–33.Google Scholar
- Keating P, Cambrosio A. Cancer on trial. Chicago: University of Chicago Press; 2012.Google Scholar
- Kristensen FB, Sigmund H, editors. Health technology assessment handbook. Copenhagen: Danish Centre for Health Technology Assessment, National Board of Health; 2007.Google Scholar
- Van der Weyden MB, Armstrong RM. Evidence and Australian health policy. MJAFI. 2004;180:607–8.Google Scholar